Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
about
Activation of G-proteins in brain by endogenous and exogenous cannabinoidsCannabinoids and Epilepsy.Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionDifferential regulation of behavioral tolerance to WIN55,212-2 by GASP1.Drug addiction.Endocrine effects of marijuana.Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virusTolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia.Differential effects of psychoactive drugs in adolescents and adultsBehavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans.Anandamide: an update.Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophreniaBehavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.Does the neuroprotective role of anandamide display diurnal variations?Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization.Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.Addiction medicine perspective on the medicalization of marijuana.CB1 and CB2 Receptor Pharmacology.Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.Differential treatment regimen-related effects of HU210 on CB(1) and D(2)-like receptor functionality in the rat basal ganglia.Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy.Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.
P2860
Q24647703-9337FCD3-5343-4CB5-8517-D7446320FDE8Q27336451-8D4CC5D2-7251-4BA3-98CE-F8EA30401460Q28078759-705D26E4-002B-4196-AE83-645BB13581A2Q28283718-D5FC4EA3-23D5-4F1E-B190-EEA92403E8A4Q34191520-475CED34-3ECB-4578-B8EB-F2D8D4499EC8Q34575484-47312B57-F7A4-46B1-B2B6-CA4B6EFAFE52Q34986755-C4210A9A-63B0-49EB-B32B-062FBDD5E034Q35119113-75CD5822-B688-47C4-93F8-8B4670555FF6Q35119940-626EE080-D23D-4EF1-9727-D474A97D1DC0Q35546602-C3BF423F-AA4C-4C75-883D-3A5A01F59ECCQ35626928-C471B93F-5028-417D-9820-3D5CF32CD642Q36001354-D4D3674D-EA74-46B0-85F3-FA3B575F04B7Q36234294-9FD939B2-6F8F-4AFB-9786-C4F48503FB21Q36455159-60EC3C61-4B11-4A66-A9D6-C751A4D7351CQ36709628-775313B3-6C83-4F26-AFEE-16F550B162E2Q36887138-98A5C60F-B6C5-4333-B0EF-A8D6B19C27F0Q36953261-90F4D2BB-25BF-4E49-953D-F45ABB886367Q39283967-9D8F9588-9F26-452F-A1F2-EFB5122BFF93Q41333517-9ED24FCB-D647-4233-B3E1-D55DC39F5BA1Q42154370-B6888F51-2902-4635-ACEA-F9DE87A6F1F4Q42725797-E222A22C-00BC-4F9C-B250-ACA0BA1FE453Q42769645-7F2225E9-6789-4724-8B70-C38340B25783Q43599706-1F54D863-095C-4633-A591-55561A2155DBQ44287837-C8E8BC01-24C5-4489-9F56-DBDCD3493366Q44858861-C3F47D67-0DDA-4BBD-9BF7-A9FABB140378Q46097005-EDB13ED1-989A-4ADE-9763-6A90E699A5ABQ47926400-40FF8D56-6BB7-4A0D-972C-2AEE37642237Q48374331-D47E4B89-8666-42B3-BCE5-40BD06279C64Q48678685-7BC6D816-0D85-40EA-89D1-D353C21C4691Q50651454-BACF033E-3694-40B2-89B5-200D06DB10EDQ51324610-2D3C9B61-0411-413A-8C00-35E8D30F59AA
P2860
Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@en
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@nl
type
label
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@en
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@nl
prefLabel
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@en
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@nl
P2093
P1476
Downregulation of rat brain ca ...... etrahydrocannabinol treatment.
@en
P2093
Fernández-Ruiz JJ
Gorriti MA
Rodríguez de Fonseca F
P356
10.1016/0091-3057(94)90108-2
P407
P577
1994-01-01T00:00:00Z